Lipids and atherosclerosis [electronic resource] / edited by C.J. Packard and D.J. Rader ; foreword by V. Fuster.

Saved in:
Bibliographic Details
Online Access: Full Text (via Taylor & Francis)
Other Authors: Packard, Christopher J., Rader, Daniel John
Format: Electronic eBook
Language:English
Published: London ; New York : Taylor & Francis, 2006.
Series:Advances in translational medical science.
Subjects:

MARC

LEADER 00000cam a2200000xa 4500
001 b11537200
003 CoU
005 20210115100838.2
006 m o d
007 cr |||||||||||
008 051223s2006 enka ob 001 0 eng d
019 |a 276790890  |a 648335355  |a 995040277  |a 1000441437  |a 1015214726  |a 1065085388  |a 1065110194  |a 1077298097  |a 1084402463 
020 |a 0203492447  |q (electronic bk.) 
020 |a 9780203492444  |q (electronic bk.) 
020 |a 9781842142295  |q (cased) 
020 |a 1842142291 
020 |z 1842142291  |q (cloth) 
035 |a (OCoLC)tfe62737277 
035 |a (OCoLC)62737277  |z (OCoLC)276790890  |z (OCoLC)648335355  |z (OCoLC)995040277  |z (OCoLC)1000441437  |z (OCoLC)1015214726  |z (OCoLC)1065085388  |z (OCoLC)1065110194  |z (OCoLC)1077298097  |z (OCoLC)1084402463 
037 |a tfe9780429209017 
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCQ  |d YDXCP  |d OCLCQ  |d CAI  |d IDEBK  |d OCLCQ  |d E7B  |d OCLCQ  |d OCLCF  |d CRCPR  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OTZ  |d TYFRS  |d OCLCQ  |d OCLCO  |d UAB  |d STF  |d OCLCA  |d OCLCQ  |d NLE  |d OCLCO  |d OCLCQ  |d COO  |d UKMGB  |d WYU  |d OCLCA  |d VT2  |d OCLCQ  |d LEAUB 
049 |a GWRE 
050 4 |a QP751  |b .L55557 2006eb 
245 0 0 |a Lipids and atherosclerosis  |h [electronic resource] /  |c edited by C.J. Packard and D.J. Rader ; foreword by V. Fuster. 
260 |a London ;  |a New York :  |b Taylor & Francis,  |c 2006. 
300 |a 1 online resource (xiv, 238 pages) :  |b illustrations. 
336 |a text  |b txt  |2 rdacontent. 
337 |a computer  |b c  |2 rdamedia. 
338 |a online resource  |b cr  |2 rdacarrier. 
490 1 |a Advances in translational medical science. 
504 |a Includes bibliographical references and index. 
505 0 0 |t Chapter 1 The assembly of very low density lipoproteins in the liver /  |r S-O. Olofsson and L. Asp --  |t chapter 2 Cardiovascular implications of partial, tissue-specific silencing of MTP /  |r C.C. Shoulders --  |t chapter 3 Acyl CoA: Diacylglycerol acyltransferases (DGATs) as therapeutic targets for cardiovascular disease /  |r J.S. Millar and J.T. Billheimer --  |t chapter 4 The biochemical and physiological roles of ACAT1 and ACAT2 in cholesterol homeostasis and atherosclerosis /  |r R.G. Lee and L.L. Rudel --  |t chapter 5 Overview of intestinal lipid metabolism /  |r T.A. Miettinen and H. Gylling --  |t chapter 6 The role of non-cholesterol sterols in the pathogenesis of atherosclerosis and their modulation by the sitosterolaemia locus /  |r E.L. Klett and S.B. Patel --  |t chapter 7 FXR: the molecular link between bile acid and lipid metabolism /  |r T. Claudel E. Sturm B. Staels F. Kuipers --  |t chapter 8 Overview of HDL and reverse cholesterol transport /  |r P. Barter --  |t chapter 9 LXR as a therapeutic target for atherosclerosis /  |r I.G. Schulman and R.A. Heyman --  |t chapter 10 Endothelial lipase and the regulation of HDL metabolism /  |r K.O. Badellino and W. Jin --  |t chapter 11 Cholesteryl ester transfer protein (CETP) inhibition as a therapeutic strategy for raising HDL-cholesterol levels and reducing atherosclerosis /  |r D.J. Rader --  |t chapter 12 Overview of insulin resistance and the metabolic syndrome /  |r N. Sattar B. Mukhopadhyay --  |t chapter 13 Peroxisome proliferator activated receptors and energy metabolism /  |r P. Gervois, J-C. Fruchart and B. Staels --  |t chapter 14 Adipocytes and their secretory products /  |r J.B. Prins --  |t chapter 15 Regulation of adipocyte triglyceride storage /  |r F. Karpe and G.D. Tan --  |t chapter 16 Role of innate immunity in atherosclerosis: immune recognition, immune activation and the atherosclerotic process /  |r J-M. Fernández-Real --  |t chapter 17 Role of CD44 in atherogenesis and its potential role as a therapeutic target /  |r E. Puré --  |t chapter 18 Lipoxygenases: potential therapeutic target in atherosclerosis /  |r L. Zhao and C.D. Funk --  |t chapter 19 Role of secretory phospholipase A2 isozymes (Lp-PLA2) /  |r C.H. Macphee. 
588 0 |a Print version record. 
650 0 |a Lipids.  |0 http://id.loc.gov/authorities/subjects/sh85077296. 
650 0 |a Atherosclerosis  |x Etiology.  |0 http://id.loc.gov/authorities/subjects/sh2009116135. 
650 0 |a Atherosclerosis  |x Treatment. 
650 7 |a Atherosclerosis  |x Etiology.  |2 fast  |0 (OCoLC)fst00820011. 
650 7 |a Atherosclerosis  |x Treatment.  |2 fast  |0 (OCoLC)fst00820020. 
650 7 |a Lipids.  |2 fast  |0 (OCoLC)fst00999367. 
700 1 |a Packard, Christopher J.  |0 http://id.loc.gov/authorities/names/n88211209  |1 http://isni.org/isni/0000000124529839. 
700 1 |a Rader, Daniel John.  |0 http://id.loc.gov/authorities/names/n89656516  |1 http://isni.org/isni/0000000029681111. 
776 0 8 |i Print version:  |t Lipids and atherosclerosis.  |d London ; New York : Taylor & Francis, 2006  |z 1842142291  |w (OCoLC)56876271. 
830 0 |a Advances in translational medical science.  |0 http://id.loc.gov/authorities/names/n2005184357. 
856 4 0 |u https://colorado.idm.oclc.org/login?url=https://www.taylorfrancis.com/books/9780429209017  |z Full Text (via Taylor & Francis) 
907 |a .b115372003  |b 10-19-21  |c 01-22-21 
998 |a web  |b 04-12-21  |c b  |d b   |e -  |f eng  |g enk  |h 0  |i 1 
907 |a .b115372003  |b 05-03-21  |c 01-22-21 
907 |a .b115372003  |b 04-12-21  |c 01-22-21 
944 |a MARS - RDA ENRICHED 
915 |a I 
956 |a Taylor & Francis eBooks 
956 |b Taylor & Francis All eBooks 
999 f f |i 02abc4d0-e724-5ea0-8154-7fc03f50a51f  |s 9df17bb3-56df-5b80-9541-5bec72c6e5e1 
952 f f |p Can circulate  |a University of Colorado Boulder  |b Online  |c Online  |d Online  |e QP751 .L55557 2006eb  |h Library of Congress classification  |i web  |n 1